US · RKDA
Arcadia Biosciences, Inc.
- Sector
- Basic Materials · Agricultural Inputs
- Headquarters
- Davis, CA 95618
- Website
- arcadiabio.com
Price · as of 2024-12-31
$1.12
Market cap 2.67M
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $343.19 | +30,541.96% |
| Intrinsic Value(DCF) | $1.77 | +58.04% |
| Graham-Dodd Method(GD) | — | — |
| Graham Formula(GF) | — | — |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2010 | |||||
| 2011 | |||||
| 2012 | |||||
| 2013 | $0.00 | $0.00 | |||
| 2014 | $0.00 | $0.00 | |||
| 2015 | $2,240.00 | $896.00 | $589.83 | $0.00 | $6,687.68 |
| 2016 | $648.00 | $267.90 | $11.15 | $0.00 | $11,067.92 |
| 2017 | $416.00 | $2,788.96 | $0.00 | $0.00 | $0.00 |
| 2018 | $293.60 | $166.41 | $0.00 | $0.00 | $7,545.19 |
| 2019 | $152.80 | $158.71 | $0.00 | $0.00 | $2,026.47 |
| 2020 | $123.60 | $220.87 | $42.82 | $16.23 | $0.00 |
| 2021 | $59.20 | $312.67 | $0.36 | $0.00 | $187.14 |
| 2022 | $8.21 | $815.26 | $19.84 | $0.00 | $0.00 |
| 2023 | $2.51 | $6.37 | $4.17 | $0.00 | $340.56 |
| 2024 | $3.40 | $343.19 | $0.80 | $0.00 | $0.00 |
AI valuation
Our deep-learning model estimates Arcadia Biosciences, Inc.'s (RKDA) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $343.19
- Current price
- $1.12
- AI upside
- +30,541.96%
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$1.77
+58.04% upside
Graham-Dodd
—
— upside
Graham Formula
—
— upside
Peer comparison
Same-industry comparables, ranked by market cap.
| Basic Info | Model Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| RKDA | Arcadia Biosciences, Inc. | $1.12 | 2.67M | +30,542% | +58% | — | — | -1.07 | 0.74 | 0.92 | -0.07 | — | 0.75 | 41.27% | -72.31% | -139.50% | -45.29% | -168.03% | -25.99% | 0.02 | — | 3.61 | 2.11 | 0.55 | -5434.00% | 1327.00% | -3697.00% | -208.10% | -3.76 | -444.17% | 0.00% | 0.00% | 0.00% | -0.15 | -0.06 | 0.11 | -28.43 |
| CAPS | Capstone Holding Corp. | $0.62 | 3.35M | +73,407% | +115% | — | — | -0.20 | -0.17 | 0.01 | -141.52 | — | -0.02 | 21.33% | -1.42% | -5.71% | 825.44% | -3.00% | -5.13% | -5.43 | -0.43 | 1.02 | 0.22 | -137.20 | -420.00% | -719.00% | 19823.00% | 707.29% | 0.30 | 20.42% | 0.00% | 0.00% | 702.32% | -26.84 | 4.63 | 0.38 | -4.90 |
| CNEY | CN ENERGY GROUP INC. | $1.01 | 3.03M | +30,775% | -62% | +8,765% | +44,217% | -0.04 | 0.00 | 0.01 | -0.39 | — | 0.00 | -20.17% | -30.85% | -31.32% | -11.20% | -10.89% | -10.83% | 0.03 | -15.49 | 13.90 | 8.44 | -0.33 | -7922.00% | -3019.00% | -1685.00% | -399.66% | -0.42 | -1.96% | 0.00% | 0.00% | 0.00% | -0.32 | -1.79 | 0.10 | 0.37 |
| FMSTW | Foremost Clean Energy Ltd… | $0.95 | 11.82M | — | — | — | — | — | — | — | — | — | — | 0.00% | — | — | -19.18% | -34.87% | -16.31% | 0.02 | -59.74 | 1.73 | 1.69 | 1.27 | -5152.00% | — | 92.00% | — | -1.22 | -24.16% | — | 0.00% | — | — | — | — | — |
| GURE | Gulf Resources, Inc. | $4.61 | 6.37M | +16,869% | +904% | — | +75,252% | -0.13 | 0.05 | 1.02 | -0.17 | — | 0.06 | -208.41% | -277.82% | -769.29% | -33.78% | -14.94% | -29.76% | 0.06 | -231.59 | 0.98 | 0.61 | 0.04 | -726.00% | -7450.00% | 8274.00% | -764.32% | 0.04 | -42.02% | 0.00% | 0.00% | 0.00% | -0.30 | -0.11 | 0.85 | 0.12 |
| INHD | Inno Holdings Inc. | $1.08 | 348.65K | — | +90,553% | — | — | -2.82 | 1.32 | 7.01 | -2.27 | — | 1.32 | 1.96% | -153.27% | -248.73% | -77.90% | -128.50% | -70.18% | 0.00 | — | 29.49 | 24.35 | 2.31 | -1761.00% | — | -1608.00% | -23.69% | -10.10 | -139.28% | 0.00% | 0.00% | 43.96% | -2.27 | -2.09 | 3.47 | 13.26 |
| NITO | N2OFF, Inc. | $1.22 | 1.16M | +2,491% | +244% | — | -71% | -326.55 | 367.67 | 8314.70 | -333.00 | — | 367.67 | 21.43% | -2057.14% | -2472.86% | -95.24% | -200.30% | -84.14% | 0.00 | -45.47 | 3.82 | 3.22 | 0.42 | -8361.00% | -2029.00% | 576.00% | -0.20% | -3.83 | -158.52% | 0.00% | 0.00% | 0.00% | -403.61 | -509.97 | 8302.87 | 1163.63 |
| RETO | ReTo Eco-Solutions, Inc. | $0.90 | 528.35K | +312,727% | +3,187% | — | +56,325% | -1.79 | 0.50 | 8.12 | -1.73 | — | 0.67 | 45.12% | -225.87% | -456.68% | -48.50% | -19.61% | -27.94% | 0.00 | -1297.85 | 0.35 | 0.21 | 0.07 | -6803.00% | -4349.00% | -6327.00% | -29.06% | 0.78 | -20.48% | 0.00% | 0.00% | 60.47% | -3.46 | -3.31 | 7.81 | -1.31 |
About Arcadia Biosciences, Inc.
Arcadia Biosciences, Inc. produces and markets plant-based health and wellness products in the United States. It engages in developing crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients, health and wellness products, and their viability for industrial applications. The company was incorporated in 2002 and is headquartered in Davis, California.
- CEO
- Thomas J. Schaefer
- Employees
- 9
- Beta
- 0.57
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($1.77 ÷ $1.12) − 1 = +58.04% (DCF, example).